Ondamed Inc.

Ondamed Inc. manufactures biofeedback medical devices based on 30+ years of European research and clinical use. The company offers non-invasive therapeutic technologies classified as Class II-a medical devices by the FDA, approved for use in clinical and home settings in the United States. ONDAMED devices employ personalized biofeedback methodology to help patients improve stress tolerance and emotional regulation through relaxation training and body awareness. The technology operates on the principle that stress is linked to common disease states, and addresses this through patient-centered, individualized treatment protocols. The devices are regulated as biofeedback medical devices in the US; regulatory classification varies internationally. ONDAMED has established a global presence across North and South America, Europe, Asia, and Australia. Biofeedback sessions using ONDAMED devices may be covered by Medicare, Medicaid, and private insurance carriers; CPT codes are available. The company positions its approach as personalized medicine, enabling patients to take an active role in their health outcomes while clinicians guide treatment. Products are designed for both clinical practice and home-use applications.